Related Experiment Video
Updated: Jan 7, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Treatment Approaches to Locally Advanced Pancreatic Adenocarcinoma
Erqi L Pollom1, Albert C Koong1, Andrew H Ko2
1Department of Radiation Oncology, Stanford Cancer Center, Stanford University, 875 Blake Wilbur Drive, MC5847, Stanford, CA 94305-5847, USA.
Abstract:
This article focuses on the management of locally advanced pancreatic cancer, which should be treated as a distinct entity separate from metastatic disease and borderline resectable disease. Although the role, timing, and sequencing of radiation relative to systemic therapy in this disease are controversial, an emerging treatment paradigm involves induction chemotherapy, followed by consolidative chemoradiation in patients who do not progress. In addition, new chemotherapy regimens as well as novel radiosensitizers have shown promise and need to be tested further in the locally advanced setting. Advances in radiotherapy have enabled stereotactic body radiotherapy and should continue to be prospectively evaluated.

